We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

TDCS in Acute Stroke (TDCS-aphasia)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01701713
Recruitment Status : Unknown
Verified October 2012 by Gerhard Jan Jungehuelsing, Charite University, Berlin, Germany.
Recruitment status was:  Recruiting
First Posted : October 5, 2012
Last Update Posted : October 8, 2012
Information provided by (Responsible Party):

September 26, 2012
October 5, 2012
October 8, 2012
June 2009
June 2013   (Final data collection date for primary outcome measure)
skin irritation [ Time Frame: 2 months ]
skin irritation, other problems [ Time Frame: 2 months ]
Complete list of historical versions of study NCT01701713 on ClinicalTrials.gov Archive Site
Improved language [ Time Frame: 2 months ]
improved picture naming
Same as current
Not Provided
Not Provided
TDCS in Acute Stroke
Safety Study of Transcranial Direct Current Stimulation in Aphasia Therapy in Acute and Post-acute Stroke
The purpose of this study is to determine the safety of transcranial direct current stimulation in aphasia therapy in acute and post-acute stroke.
TDCS has been shown to have a positive effect on clinical outcome in both motor rehabilitation and aphasia treatment in chronic aphasic patients. In healthy subjects the method sped up reaction times in naming and language learning tasks. In TDCS a weak current is applied to the subjects head increasing excitatory activity which might lead to improved brain function.
Not Provided
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double (Participant, Outcomes Assessor)
Primary Purpose: Supportive Care
  • Device: DKI ED2011
  • Device: Sham-TDCS
  • Experimental: TDCS - DKI ED2011
    TDCS with DKI ED2011 session is followed by a behavioral naming therapy with different cues
    Intervention: Device: DKI ED2011
  • Sham Comparator: Sham-TDCS
    Sham-TDCS session is followed by a behavioral naming therapy with different cues
    Intervention: Device: Sham-TDCS
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
Unknown status
June 2013
June 2013   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • first media stroke
  • language impairment
  • informed consent
  • right handedness
  • NIHSS < 20

Exclusion Criteria:

  • previous Epilepsy oder epileptogenic events
  • epilepsy typical elements in EEG
  • hypersensitive skin (head)
  • metal implants (head)
  • pace maker or other electronic implants
  • previous head/brain surgery
  • medication reducing seizure threshold
  • previous psychiatric events
Sexes Eligible for Study: All
18 Years to 85 Years   (Adult, Senior)
Contact information is only displayed when the study is recruiting subjects
EA4/109/08 ( Other Identifier: Charité Ethics Committee )
Not Provided
Not Provided
Gerhard Jan Jungehuelsing, Charite University, Berlin, Germany
Charite University, Berlin, Germany
  • German Federal Ministry of Education and Research
  • Brandenburg Klinik, Bernau, Germany
  • University of Potsdam
Principal Investigator: Gerhard J Jungehuelsing, MD Center for Stroke Research Berlin (CSB), Charité
Principal Investigator: Michael Joebges, Prof. MD Brandenburgklinik Bernau
Charite University, Berlin, Germany
October 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP